A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...

Pfizer CEO Albert Bourla appeared on ABC's "This Week." Pfizer CEO Albert Bourla said on ABC's "This Week" Sunday it's possible to provide both COVID-19 booster shots as well as doses for people who ...

In new data released by the Food and Drug Administration on Wednesday, Pfizer said vaccine booster shots would restore protection against COVID-19 to up to 95% in real-world settings, CNBC and ABC ...

The group will discus and vote on whether to recommend Pfizer booster shots. The Food and Drug Administration's independent advisory committee will convene in open session Friday to review the latest ...

A key advisory panel to the Centers for Disease Control and Prevention (CDC) voted Thursday to endorse the administration of Pfizer’s COVID-19 booster shots to those 65 and older, nursing home ...

Pfizer's CEO confirmed on Twitter that they seek emergency use authorization to provide a second COVID-19 booster shot for adults 65 years and older. Albert Bourla said that they submitted the ...

The US Food and Drug Administration has granted emergency use authorization for a booster dose of Pfizer/BioNTech's COVID-19 vaccine for children ages 5 to 11 at least five months after completion of ...

On Tuesday, the Centers for Disease Control and Prevention updated recommendations for booster shots, saying that people who got the Pfizer vaccine should now seek out a booster shot five months after ...

NEW YORK, N.Y. — Pfizer and BioNTech announced Tuesday that they’ve made a request for the Food and Drug Administration (FDA) to authorize their COVID-19 booster shot for all adults. Specifically, the ...

Pfizer is asking the Food and Drug Administration (FDA) to expand booster shot eligibility to 16- and 17-year-olds “It is our hope to provide strong protection for as many people as possible, ...